Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases
Graeme L. Card, Bruce P. England, Yoshihisa Suzuki et al. · Structure · 2004
Cited by 432 works. doi:10.1016/j.str.2004.10.004 Open-access PDF
Authors
- Graeme L. Card
- Bruce P. England
- Yoshihisa Suzuki
- Ben Powell
- Catherine A. Luu
- Maryam Tabrizizad
- Sam Gillette
- Prabha N. Ibrahim
- Dean R. Artis
- Gideon E. Bollag
- Michael V. Milburn
- Sung‐Hou Kim
- Joseph Schlessinger
- Kam Y. J. Zhang
References
- Improved methods for building protein models in electron density maps and the location of errors in these models
- Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
- Aromatic-Aromatic Interaction: A Mechanism of Protein Structure Stabilization
- Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
- The integration of macromolecular diffraction data
- Efficient anisotropic refinement of macromolecular structures using FFT
- EFFECTS OF SILDENAFIL ON THE RELAXATION OF HUMAN CORPUS CAVERNOSUM TISSUE IN VITRO AND ON THE ACTIVITIES OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ISOZYMES
- Cyclic GMP Phosphodiesterase-5: Target of Sildenafil
- Cyclic nucleotide research — still expanding after half a century
- PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization